Jane Eagleson

Corporate Officer/Principal presso Bleecker Street Consulting

73 anni

Health Technology

Consumer Services

Commercial Services

Profilo

Jane Eagleson is the owner of Bleecker Street Consulting.
She previously worked as Senior Director-Asian Business Development at Pfizer Inc., Independent Director at Zomedica Corp., Head-Growth Strategies at Argenta Ltd., Vice President-Clinical & Regulatory Affairs at Nexvet Australia Pty Ltd., and Vice President of Clinical & Regulatory Affairs at Nexvet US, Inc. She received an undergraduate degree from The University of Sydney and a graduate degree from Massey University.

Posizioni attive di Jane Eagleson

Società	Posizione	Inizio
Bleecker Street Consulting Bleecker Street Consulting Agricultural Commodities/MillingProcess Industries Bleecker Street Consulting provides advice and assistance in the selection, development, and registration of animal health pharmaceutical products. The private company is based in New York, NY.	Corporate Officer/Principal	-

Tutte le posizioni attive di Jane Eagleson

Precedenti posizioni note di Jane Eagleson

Società	Posizione	Fine
Argenta Ltd. Argenta Ltd. BiotechnologyHealth Technology Argenta Ltd. operates as a pharmaceutical contract manufacturing company. It serves animal health research, veterinary, and GMP manufacting. The company was founded by Douglas Robert Cleverly in 2006 and is headquartered in Manurewa, New Zealand.	Corporate Officer/Principal	-
Nexvet US, Inc. Nexvet US, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Zoetis, Inc., Nexvet US, Inc. engages in biological research. The company is based in San Francisco, CA.	Direttore Tecnico/Scientifico/R&S	-
Nexvet Australia Pty Ltd. Nexvet Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Nexvet Australia Pty Ltd. operates as a global clinical-stage biopharmaceutical company that develops and distributes medicines for companion animals. The firm focuses on transforming the therapeutic market by developing and commercializing novel biologic therapies, including products derived from its PETization technology. PETization is designed to rapidly create monoclonal antibodies that are recognized as “self” by a patient’s immune system. The company was founded by Mark Heffernan, Christopher Nigel Brown and David Gearing in February 2010 and is headquartered in Melbourne, Australia.	Consigliere Generale	-
PFIZER, INC.	Corporate Officer/Principal	-
ZOMEDICA CORP.	Direttore/Membro del Consiglio	-

Vedi nel dettaglio l'esperienza di Jane Eagleson

Formazione di Jane Eagleson

The University of Sydney	Undergraduate Degree
Massey University	Graduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private